Clinical Trials for Classical Hodgkin Lymphoma

Find clinical trials for classical hodgkin lymphoma. Discover research opportunities and treatment options in your area.

17 Active Trials Found

Showing 17 trials on this page

Page 1 of 1

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

NCT ID: NCT04288726

This clinical trial is studying a new treatment for patients with certain types of lymphoma, including Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. The researchers are testing a special ty...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers.

NCT ID: NCT06870487

This clinical trial is designed to investigate a new medicine called PF-08046032 for adults with advanced cancers, specifically certain types of lymphomas and solid tumors. The study aims to unders...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Barcelona, , Spain +8 more

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

NCT ID: NCT02332668

This clinical trial is investigating a medication called pembrolizumab, which helps the immune system fight certain types of cancers in children, including melanoma (a type of skin cancer), solid t...

Recruiting

Phase: PHASE1 Type: interventional Locations: North Ryde, , Australia, Rome, , Italy +25 more

Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

NCT ID: NCT06822855

This clinical trial is studying how to better understand and treat Classical Hodgkin Lymphoma (cHL), a type of cancer that primarily affects young adults and is generally treatable. The researchers...

Recruiting

Type: observational Locations: Padova, , Italy, Perugia, , Italy +11 more

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT ID: NCT05362773

This clinical trial is studying a new treatment called MGD024 for patients with specific types of blood cancers that haven’t responded to standard treatments or have come back after treatment. The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Saint Louis, Missouri, United States +6 more

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

NCT ID: NCT04067037

This clinical trial is studying a new treatment for patients with advanced classical Hodgkin's lymphoma, a type of cancer that affects the lymphatic system. The researchers want to see how well a c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Zhengzhou, Henan, China

Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma

NCT ID: NCT06916416

This clinical trial is studying a new treatment approach for early-stage classical Hodgkin Lymphoma (cHL), which is a type of cancer that affects the lymphatic system. The researchers are looking a...

Not yet recruiting

Phase: PHASE2 Type: interventional

Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study

NCT ID: NCT06848569

This clinical trial is studying a new treatment approach for children and teenagers with low-to-moderate risk classical Hodgkin lymphoma, a type of cancer that affects the lymphatic system. Researc...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Brentuximab Vedotin for Newly Diagnosed CHL in Chinese CAYA Based on PET/CT Assessment

NCT ID: NCT06563245

This clinical trial is studying a treatment called Brentuximab vedotin (Bv) for children, adolescents, and young adults who have recently been diagnosed with classical Hodgkin lymphoma (cHL). The g...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China

Lifestyles Implemented-Survivorship Care Plan in Lymphoma Survivors

NCT ID: NCT05934084

This clinical trial is looking at how a healthy lifestyle can improve the quality of life for people who have survived certain types of lymphoma—specifically, classical Hodgkin lymphoma and two for...

Recruiting

Phase: NA Type: interventional Locations: Sassuolo, , Italy, Torino, , Italy +38 more

CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma

NCT ID: NCT06617286

This clinical trial is studying a new treatment approach for young patients with a type of cancer called classical Hodgkin Lymphoma (cHL) who are considered to be at high risk. The trial will first...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Valhalla, New York, United States

Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma

NCT ID: NCT04838652

This clinical trial is studying a new treatment approach for patients with classical Hodgkin lymphoma (cHL) who have either relapsed after initial treatment or did not respond to their first treatm...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cologne, , Germany

Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma

NCT ID: NCT04837859

This clinical trial is studying a new personalized treatment approach for early-stage unfavorable classical Hodgkin lymphoma (cHL), a type of blood cancer. The goal is to see if this individualized...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cologne, , Germany

Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above

NCT ID: NCT05404945

This clinical trial is studying a new treatment approach for older patients (60 years and above) with classical Hodgkin lymphoma, a type of cancer that affects the lymphatic system. The researchers...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Charlottesville, Virginia, United States +1 more

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

NCT ID: NCT04510636

This clinical trial is studying the combination of two treatments, pembrolizumab and bendamustine, for patients with classical Hodgkin lymphoma that has come back after treatment (relapsed) or is n...

Recruiting

Phase: PHASE2 Type: interventional Locations: Toronto, Ontario, Canada, Toronto, Ontario, Canada

A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma

NCT ID: NCT05900765

This clinical trial is examining how well a new treatment called Zimberelimab works when combined with a standard chemotherapy regimen (AVD) for patients with early-stage classical Hodgkin lymphoma...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

NCT ID: NCT03552003

This clinical trial is studying elderly patients who are 65 years and older and have been newly diagnosed with classical Hodgkin lymphoma, a type of cancer that affects the lymphatic system. The go...

Recruiting

Type: observational Locations: Sassuolo, , Italy, Torino, , Italy +42 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions